PHILADELPHIA, July 24, 2017 /PRNewswire/ -- Aberdeen Israel
Fund, Inc. (the "Fund") (NYSE MKT: ISL), a closed-end equity
fund, announced today its performance data and portfolio
composition as of June 30, 2017.
The Fund's total returns for various periods through
June 30, 2017 are provided below.
(All figures are based on distributions reinvested at the dividend
reinvestment price and are stated net-of-fees):
|
Cumulative as of
06/30/17
|
Annualized as of
06/30/17
|
|
1
Month
|
3
Month
|
YTD
|
1
Year
|
3
Years
|
5
Years
|
10
Years
|
Since
Inception
|
NAV
|
1.8
|
8.4
|
15.5
|
20.9
|
5.6
|
12.2
|
6.3
|
7.5
|
Market
Price
|
3.3
|
10.3
|
20.3
|
22.8
|
5.6
|
12.0
|
5.5
|
6.9
|
TA-125
|
0.9
|
7.1
|
10.8
|
17.4
|
0.4
|
8.3
|
3.6
|
n/a¹
|
¹ There is no since
inception figure for the TA-125 Index because the inception date of
the index is January 1, 1999.
|
On June 30, 2017, the Fund's net
assets amounted to US$87.2 million
and the Fund's NAV per share was US$22.11.
As of June 30, 2017, the portfolio
was invested as follows:
Portfolio
Composition
|
Percent of
Net Assets
|
Information
Technology
|
32.6
|
Financials
|
16.0
|
Health
Care
|
12.4
|
Materials
|
11.5
|
Consumer
Staples
|
8.0
|
Real
Estate
|
5.1
|
Industrials
|
4.7
|
Telecommunications
|
4.7
|
Consumer
Discretionary
|
3.2
|
Cash
|
1.8
|
The Fund's ten largest equity holdings as of June 30, 2017, representing 67.0% of net assets,
were:
Stock
|
Percent
of
Net
Assets
|
Check Point Software
Technologies
|
11.8
|
Frutarom
Industries
|
9.6
|
Ituran Location and
Control
|
7.5
|
Perrigo
|
6.9
|
Teva Pharmaceutical
Industries
|
6.6
|
Nice Systems
Ltd.
|
5.3
|
Rami Levy
|
4.9
|
Mizrahi Tefahot
Bank
|
4.8
|
Azrieli
Group
|
4.8
|
Bank
Hapoalim
|
4.7
|
Important Information
Aberdeen Asset Management Inc.
has prepared this report based on information sources believed to
be accurate and reliable. However, the figures are unaudited
and neither the Fund, Aberdeen Asset Managers Limited (the
Investment Adviser), nor any other person guarantees their
accuracy. Investors should seek their own professional advice
and should consider the investment objectives, risks, charges and
expenses before acting on this information.
Aberdeen Asset Managers Limited (the "Investment Adviser") and
Aberdeen Asset Management Inc. (the "Administrator") are each a
subsidiary of Aberdeen Asset Management PLC ("Aberdeen PLC").
On March 6, 2017, the Boards of
Standard Life plc and Aberdeen PLC announced that they had reached
an agreement on the terms of a merger ("Merger"). The Boards of
each of Standard Life plc and Aberdeen PLC believe that the Merger
has a compelling strategic and financial rationale through
combining complementary strengths to create a world-class
investment group. The Merger is expected to occur in the third
quarter of 2017, subject to various conditions and terms, including
regulatory approvals. The portfolio management team for the Fund is
not expected to change as a result of the Merger. In addition,
the agreements that the Fund has with Aberdeen PLC's subsidiary
companies, the services provided by such companies, and the fees
charged for those services are not expected to change as a result
of the Merger.
Closed-end funds are traded on the secondary market through one
of the stock exchanges. The Fund's investment return and principal
value will fluctuate so that an investor's shares may be worth more
or less than the original cost. Shares of closed-end funds may
trade above (a premium) or below (a discount) the net asset value
(NAV) of the fund's portfolio. There is no assurance that the Fund
will achieve its investment objective.
Total return figures with distributions reinvested at the
dividend reinvestment price are stated net-of-fees and represents
past performance. Past performance is not indicative of future
results, current performance may be higher or lower. Holdings
are subject to change and are provided for informational purposes
only and should not be deemed as a recommendation to buy or sell
the securities shown. Inception date October 29, 1992.
If you wish to receive this information
electronically, please contact:
InvestorRelations@aberdeen-asset.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/aberdeen-israel-fund-inc-announces-performance-data-and-portfolio-composition-300492561.html
SOURCE Aberdeen Israel Fund, Inc.